Efficacy analysis of ultrasound-guided percutaneous radiofrequency ablation in the treatment of nonmetastatic pheochromocytoma
10.3760/cma.j.cn131148-20210827-00600
- VernacularTitle:超声引导下经皮射频消融治疗非转移性嗜铬细胞瘤的效果分析
- Author:
Yuang ZHANG
1
;
Qinying LI
;
Gang DONG
;
Lulu SUN
;
Jiamin SUN
;
Shanshan ZHANG
;
Mengfan PENG
Author Information
1. 郑州大学第一附属医院超声科，郑州 450000
- Keywords:
Ultrasound-guidance;
Radiofrequency ablation;
Nonmetastatic pheochromocytoma;
Methoxypinephrine;
Normetanephrine
- From:
Chinese Journal of Ultrasonography
2022;31(2):129-134
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation in the treatment of nonmetastatic pheochromocytoma.Methods:A retrospective analysis was performed on 7 patients with nonmetastatic pheochromocytoma admitted to the First Affiliated Hospital of Zhengzhou University from January 2018 to June 2020, all of whom underwent ultrasound-guided percutaneous radiofrequency ablation. The changes of postoperative blood pressure, improvement of symptoms, intraoperative and postoperative complications were observed.Plasma free methoxypinephrine (MN) and normetanephrine (NMN) levels were recorded before and 2 weeks after operation. The reduction rate of ablation lesion volume at 1, 3 and 6 months after operation was calculated.Results:Postoperative blood pressure of all 7 patients was reduced to the normal range within 3 days, and symptoms such as headache were significantly relieved immediately after operation.No serious complications occurred during or after operation. Plasma free MN and NMN levels decreased to normal levels 2 weeks after operation. The mean reduction rates of the ablation lesions at 1, 3 and 6 months after operation were (46.61±13.42)%, (67.21±10.54)% and (85.73±4.15)%, respectively. Postoperative follow-up of 12-30 months showed that the blood pressure, plasma free MN and NMN levels of the patients were all in the normal range, and no symptoms such as headache and palpitation occurred again. All the tumors were completely ablated, and no recurrence was observed.Conclusions:Ultrasound-guided percutaneous radiofrequency ablation in the treatment of nonmetastatic pheochromocytoma is minimally invasive, safe and effective, and can retain adrenal cortex function, which is worthy of clinical promotion.
